ZyVersa shareholders approve reverse stock split; board sets 1-for-10 ratio

ZyVersa Therapeutics, Inc.

Shareholders approved reverse stock split at special meeting on April 17, 2024, with 2,058,182 votes for and 899,831 against.
Board of directors subsequently authorized a 1-for-10 reverse stock split ratio.
Reverse stock split effective at 4:01 p.m. ET on April 25, 2024; post-split trading begins April 26, 2024.
New CUSIP number for common stock after reverse split: 98987D 300.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.